Clinical efficacy of 300IR five-grass pollen sublingual tablet by baseline timothy-specific serum IgE in a US study

被引：0
|
作者：
Cox, L. [1 ]
Casale, T. [2 ]
Creticos, P. [3 ]
Ambroisine, L. [4 ]
Le Gall, M. [4 ]
Melac, M. [4 ]
Zeldin, R. [4 ]
机构：
[1] Nova SE Univ, Sch Osteopath Med, Davie, FL USA
[2] Creighton Univ Allergy & Asthma, Dept Med, Div Allergy & Immunol, Omaha, NE USA
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Stallergenes, Antony, France
来源：
ALLERGY | 2012年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1101
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [41] Post-treatment, Long-term Efficacy Of A 300IR Sublingual Tablet Of 5-grass Pollen Allergen Extract In Adults With Grass Pollen-induced Allergic Rhinoconjunctivitis: The Relationship With Disease Severity
    Worm, M.
    Didier, A.
    Horak, F.
    Malling, H.
    Soulie, S.
    Zeldin, R. K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB47 - AB47
  • [42] PEDIATRIC OBSERVATIONAL STUDY OF 300IR 5-GRASS TABLET IN GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS: FURTHER SAFETY DATA
    Geng, B.
    Gerstlauer, M.
    Szepfalusi, Z.
    de Bilc, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S30 - S30
  • [43] Sustained Efficacy and Safety Of a Pre-coseasonal 300IR 5-grass Pollen SLIT Tablet Over 3 Pollen Seasons In Adult SAR
    Didier, A.
    Worm, M.
    Horak, F.
    Melac, M.
    De Beaumont, O.
    Le Gall, M.
    Montagut, A.
    Galvain, S.
    Malling, H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB151 - AB151
  • [44] Relationship between disease severity and post-treatment, long-term efficacy of 300IR 5-grass pollen sublingual tablets
    Didier, A.
    Malling, H.
    Worm, M.
    Amistani, Y.
    Le Gall, M.
    Zeldin, R.
    ALLERGY, 2012, 67 : 135 - 135
  • [45] Post-treatment, Long-term Clinical Efficacy Of A 300 IR Sublingual Tablet of 5-grass Pollen Allergen Extract In Adults With Grass Pollen-induced Allergic Rhinoconjunctivitis
    Malling, H.
    Didier, A.
    Horak, F.
    Worm, M.
    de Beaumont, O.
    Rodriguez, P.
    Montagut, A.
    Zeldin, R. K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB144 - AB144
  • [46] Consistency Of Clinical Results Throughout Short-term And Long-term Studies With Sublingual 300IR 5-grass Pollen Tablets
    Bachert, C.
    Didier, A.
    Wahn, H.
    Le Gall, M.
    De Beaumont, O.
    Melac, M.
    Montagut, A.
    Malling, H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB49 - AB49
  • [47] Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score
    Didier, Alain
    Malling, Hans-Jorgen
    Worm, Margitta
    Horak, Friedrich
    Sussman, Gordon L.
    CLINICAL AND TRANSLATIONAL ALLERGY, 2015, 5
  • [48] Design and objectives of ALTO: a 5-year observational study evaluating the quality of life of allergic rhino-conjunctivitis patients treated by 300IR 5-grass pollen sublingual tablet
    Didier, A.
    Bousquet, P-J
    Davila, I
    Pfaar, O.
    Robin, B.
    ALLERGY, 2014, 69 : 611 - 611
  • [49] Safety Of 300IR 5-Grass Tablet In Grass Pollen-Allergic Children With Or Without Controlled Asthma: Further Data From A Post-Marketing Observational Study
    Golden, David B. K.
    Gerstlauer, Michael
    Szepfalusi, Zsolt
    De Blic, Jacques
    Geng, Bob
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB198 - AB198
  • [50] Efficacy of 300IR 5-grass pollen extract sublingual tablet assessed by daily combined score: results of three double-blind placebo-controlled natural field studies in children/adolescents and adults
    Wahn, U.
    Malling, H-J
    Cox, L. S.
    Soulie, E.
    Zeldin, R. K.
    ALLERGY, 2013, 68 : 550 - 551
12345